Works matching IS 25233548 AND DT 2024 AND VI 44 AND IP 11

Results: 9

Partial hepatectomy versus interventional treatment in patients with hepatitis B virus‐related hepatocellular carcinoma and clinically significant portal hypertension: a randomized comparative clinical trial.

Published in:

Cancer Communications, 2024, v. 44, n. 11, p. 1337, doi. 10.1002/cac2.12614

By:

Yuan, Yichuan;
Peng, Hong;
He, Wei;
Zheng, Yun;
Qiu, Jiliang;
Chen, Bin;
Zou, Ruhai;
Wang, Chenwei;
Lau, Wan Yee;
Li, Binkui;
Yuan, Yunfei

Publication type:

Article

Deciphering protective genomic factors of tumor development in pediatric Down syndrome via deep learning approach to whole genome and RNA sequencing.

Published in:

Cancer Communications, 2024, v. 44, n. 11, p. 1374, doi. 10.1002/cac2.12612

By:

Liu, Yichuan;
Qu, Hui‐Qi;
Chang, Xiao;
Mentch, Frank D;
Qiu, Haijun;
Nguyen, Kenny;
Ostberg, Kayleigh;
Wang, Tiancheng;
Glessner, Joseph;
Hakonarson, Hakon

Publication type:

Article

Altered glycosylation in cancer: molecular functions and therapeutic potential.

Published in:

Cancer Communications, 2024, v. 44, n. 11, p. 1316, doi. 10.1002/cac2.12610

By:

Xu, Xuemeng;
Peng, Qiu;
Jiang, Xianjie;
Tan, Shiming;
Yang, Wenjuan;
Han, Yaqian;
Oyang, Linda;
Lin, Jinguan;
Shen, Mengzhou;
Wang, Jiewen;
Li, Haofan;
Xia, Longzheng;
Peng, Mingjing;
Wu, Nayiyuan;
Tang, Yanyan;
Wang, Hui;
Liao, Qianjin;
Zhou, Yujuan

Publication type:

Article

Issue Information.

Published in:: Cancer Communications, 2024, v. 44, n. 11, p. 1229, doi. 10.1002/cac2.12440
Publication type:: Article

Yap methylation‐induced FGL1 expression suppresses anti‐tumor immunity and promotes tumor progression in KRAS‐driven lung adenocarcinoma.

Published in:

Cancer Communications, 2024, v. 44, n. 11, p. 1350, doi. 10.1002/cac2.12609

By:

Jiang, Ji;
Ye, Pengfei;
Sun, Ningning;
Zhu, Weihua;
Yang, Mei;
Yu, Manman;
Yu, Jingjing;
Zhang, Hui;
Gao, Zijie;
Zhang, Ningjie;
Guo, Shijie;
Ji, Yuru;
Li, Siqi;
Zhang, Cuncun;
Miao, Sainan;
Chai, Mengqi;
Liu, Wenmin;
An, Yue;
Hong, Jian;
Wei, Wei

Publication type:

Article

Single‐cell transcriptomic atlas reveals immune and metabolism perturbation of depression in the pathogenesis of breast cancer.

Published in:

Cancer Communications, 2024, v. 44, n. 11, p. 1311, doi. 10.1002/cac2.12603

By:

Wu, Lingling;
Liu, Junwei;
Geng, Yimeng;
Fang, Jianwen;
Gao, Xingle;
Lai, Jianbo;
Yao, Minya;
Lu, Shaojia;
Yin, Weiwei;
Fu, Peifen;
Chen, Wei;
Hu, Shaohua

Publication type:

Article

Tryptophan 2,3‐dioxygenase‐positive matrix fibroblasts fuel breast cancer lung metastasis via kynurenine‐mediated ferroptosis resistance of metastatic cells and T cell dysfunction.

Published in:

Cancer Communications, 2024, v. 44, n. 11, p. 1261, doi. 10.1002/cac2.12608

By:

Liu, Yongcan;
Chen, Shanchun;
Wan, Xueying;
Wang, Rui;
Luo, Haojun;
Chang, Chao;
Dai, Peijin;
Gan, Yubi;
Guo, Yuetong;
Hou, Yixuan;
Sun, Yan;
Teng, Yong;
Cui, Xiaojiang;
Liu, Manran

Publication type:

Article

Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti‐PD‐1 therapy in hepatocellular carcinoma.

Published in:

Cancer Communications, 2024, v. 44, n. 11, p. 1231, doi. 10.1002/cac2.12607

By:

Cai, Jialiang;
Song, Lina;
Zhang, Feng;
Wu, Suiyi;
Zhu, Guiqi;
Zhang, Peiling;
Chen, Shiping;
Du, Junxian;
Wang, Biao;
Cai, Yufan;
Yang, Yi;
Wan, Jinglei;
Zhou, Jian;
Fan, Jia;
Dai, Zhi

Publication type:

Article

Local TSH/TSHR signaling promotes CD8<sup>+</sup> T cell exhaustion and immune evasion in colorectal carcinoma.

Published in:

Cancer Communications, 2024, v. 44, n. 11, p. 1287, doi. 10.1002/cac2.12605

By:

Zeng, Sisi;
Hu, Huiling;
Li, Zhiyang;
Hu, Qi;
Shen, Rong;
Li, Mingzhou;
Liang, Yunshi;
Mao, Zuokang;
Zhang, Yandong;
Zhan, Wanqi;
Zhu, Qin;
Wang, Feifei;
Xiao, Jianbiao;
Xu, Bohan;
Liu, Guanglong;
Wang, Yanan;
Li, Bingsong;
Xu, Shaowan;
Zhang, Zhaowen;
Zhang, Ceng

Publication type:

Article